Rapid Fieldable Biodosimetry Assay

In the event of a nuclear detonation event it will be imperative to readily detect the level of radiation exposure to soldiers or civilians. For warfighters it will be important to determine whether they can be sent back into harm’s way and for civilians it will be important to triage victims into treatable and untreatable groups. Whole body exposure to even 0.5 Gy, >100 times the yearly background radiation, carries low risk. However, 1 Gy can markedly increase cancer risk and induce subclinical or mild radiation sickness, meriting mitigation, observation and follow-up. 2 Gy will deplete bone marrow progenitors, leading to high risk of infection and sepsis over days to weeks. Solulink proposes to develop Rapid Fieldable Biodosimeter test based on detection of a biomarker that correlates directly with the level of radiation exposure.